Triple-negative breast cancer (TNBC), which is characterized by the absence of the estrogen (ER) and progesterone (PR) receptors and the human epidermal growth factor receptor 2 (HER2), is the most aggressive breast cancer subtype and has a poor prognosis [2]. Here, ERBB2 is linked to breast cancer.